Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Other: Non-interventional

Study type: Observational

Funder types: Industry

Identifiers

NCT03313167

CV185-595

Details and patient eligibility

About

To assess the prevalence of all (prevalent and paroxysmal) undiagnosed atrial fibrillation (AF) in a Japanese population with a moderate-to-high risk of stroke

Enrollment: 1,316 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 65 and one or more of the following: hypertension, prior stroke or transient ischemic attack, congestive heart failure, diabetes mellitus, and/or vascular disease

Exclusion criteria

• Age < 65 years, individuals with AF or a history of AF, or individuals taking anti-arrhythmic drugs

Other protocol defined inclusion/exclusion criteria could apply

Trial design

1,316 participants in 1 patient group

Atrial Fibrillation-potential Patients

Description:

individuals 65 years of age or older with moderate-to-high risk of stroke

Treatment:

Other: Non-interventional